Proprenz Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 01-07-2024
- Paid Up Capital ₹ 2.50 M
as on 01-07-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.22 M
as on 01-07-2024
- Revenue 44.09%
(FY 2023)
- Profit 44.80%
(FY 2023)
- Ebitda 22.73%
(FY 2023)
- Net Worth 118.12%
(FY 2023)
- Total Assets -4.18%
(FY 2023)
About Proprenz Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹9.22 M.
Sudhakar Venigalla and Prasuna Goalla serve as directors at the Company.
- CIN/LLPIN
U01111TG2018PTC122564
- Company No.
122564
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 2018
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Proprenz Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhakar Venigalla  | Director | 18-Nov-2019 | Current |
| Prasuna Goalla | Director | 27-Feb-2018 | Current |
Financial Performance of Proprenz Biotech.
Proprenz Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.09% increase. The company also saw a substantial improvement in profitability, with a 44.8% increase in profit. The company's net worth Soared by an impressive increase of 118.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Proprenz Biotech?
In 2023, Proprenz Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 09 May 2023 | ₹5.00 M | Open |
Hdfc Bank Limited Creation Date: 29 Oct 2021 | ₹3.00 M | Open |
Hdfc Bank Limited Creation Date: 08 Jan 2021 | ₹1.22 M | Open |
How Many Employees Work at Proprenz Biotech?
Unlock and access historical data on people associated with Proprenz Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Proprenz Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proprenz Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
